| Literature DB >> 9951693 |
D E Tsai1, E A Stadtmauer, D J Canaday, D J Vaughn.
Abstract
The optimal treatment for posttransplant lymphoproliferative disorder which has progressed despite a reduction in immunosuppression has not been defined. We report on two patients with stage I posttransplant lymphoproliferative disorder who developed progressive disease despite a reduction in the level of immunosuppression. Both patients were treated with combined short course CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy followed by involved-field radiation therapy. In both patients, a rapid response was obtained followed by complete remission. Combined modality therapy can be utilized successfully in progressive limited stage posttransplant lymphoproliferative disorder.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9951693 DOI: 10.1007/BF02787213
Source DB: PubMed Journal: Med Oncol ISSN: 1357-0560 Impact factor: 3.064